James came into market research with an education in international finance and is extremely interested in the business of healthcare. He has been involved in and led teams that focus on vaccines research for over 20 years. His work has included research into all phases of product lifecycle: from understanding the potential of early phase projects, to communications to defend a mature brand from new entrants. A Riva trained seasoned moderator James has personally spoken with thousands of patients, parents, nurses, doctors, KOLs, pharmacists, purchasers etc. He has conducted market research in all areas of the world in pediatric, adult, seasonal, travel and investigational vaccines and brings both a broad and deep understanding of vaccines to the team.

Mollie’s market research background spans both agency and clientside roles and her career is driven by an insatiable curiosity to understand human behaviour and what and how to influence it. Joining HRW in 2023, Mollie was keen bring her broad vaccine experience to the HRW Boost team from its inception. She has done extensive work in vaccines and infectious disease where she has a particular expertise in applying quantitative methodologies. Mollie has a deep interest in exploring perceptions of vaccine-preventable conditions amongst patients, providers and the general public, and identifying ways to drive behavior change that will encourage broad uptake of vaccines in order to reduce the spread and impact of preventable disease.

Melissa brings to the HRW Boost Team nearly a decade’s worth of experience leading primary marketing research studies in the vaccine space. She has supported numerous manufacturers across a wide range of vaccine preventable diseases including: COVID-19, influenza, meningococcal meningitis, pneumococcal disease, RSV, pediatric combinations, and others. Melissa, perpetually curious about the drivers of human behavior, is fascinated by the unique decision-making process and environment of physician, pharmacists, buyer, and consumers with regard to vaccines. She is a master of translating insights into actionable recommendations for her clients.

With a keen interest in public health, and a desire to make a positive impact on society, Alicia’s market research career has been almost entirely devoted to the healthcare space. While Alicia has a breadth of experience across a number of therapy areas, her work in infectious diseases (tuberculosis, HIV etc.) and paediatric vaccines (RSV, seasonal vaccines) has been particularly rewarding.

Annabelle achieved her degree in Psychology from King’s College London University. While her focus of study was Clinical Psychology, her interest in understanding human behavior led her to a career in market research. Personally, she is deeply interested in public health and preventative medicine. She believes vaccines are a powerful force within public healthcare and is vitally interested in supporting efforts that positively impact attitudes and accessibility. Annabelle is experienced working on and managing large multi-country market research initiatives both qualitative and quantitative.

Elyse joined the HRW team with an academic background in life sciences and public health and is currently pursuing her Masters of Public Health at NYU. She is driven by informing healthcare solutions that allow for broader access and adoption to life-saving therapies, like those provided through vaccines. A passionate researcher, Elyse uses her academic background in health management in conjunction with deep subject matter interest to generate meaningful and actionable insights for clients.

Jess is a Vice President in the US and works closely with James, overseeing the Boost team. She has a BSc in Biology and a keen interest in preventative health and the evolution of medicine. Combined with her passion for understanding client strategy and business needs, she supports the team with partnership that leads to commercial success.

As part of her Biomedical Sciences undergraduate degree, Imogen enrolled onto virology and immunology courses, demonstrating a keen interest in the prevention and treatment of infectious disease. Since joining HRW in 2022, Imogen has worked on various projects in this space, including work on HPV and HIV, in which she helped provide valuable and actionable insights for her clients.